XML 64 R4.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Statements of Operations - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Operating expenses:    
Research and development $ 14,478 $ 15,859
General and administrative 9,726 22,216
Total operating expenses 24,204 38,075
Consolidated operating loss (24,204) (38,075)
Change in fair value of financial instruments 9,490 3,168
Other income 1,014 550
Total other income 10,504 3,718
Net loss $ (13,700) $ (34,357)
Net loss per share - basic $ (1.22) $ (7.66)
Net loss per share - diluted $ (1.22) $ (7.66)
Weighted-average number of shares outstanding used in computing net loss per share - basic 11,245,915 4,486,258
Weighted-average number of shares outstanding used in computing net loss per share - diluted 11,245,915 4,486,258